Akebia Therapeutics (AKBA) Receivables - Other (2016 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Receivables - Other of $300000.0 for Q1 2026, down 80.84% year-over-year from $1.6 million in Q1 2025, and down 87.45% quarter-over-quarter from $2.4 million in Q4 2025.
Akebia Therapeutics (AKBA) Receivables - Other (2016 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Receivables - Other for 11 consecutive years, with $300000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other fell 80.84% year-over-year to $300000.0; the TTM figure through Mar 2026 stood at $300000.0 (down 80.84% YoY), while the FY2025 annual figure was $2.4 million, up 18.96% from the prior year.
- Receivables - Other declined to $300000.0 in Q1 2026 per AKBA's latest filing, from $2.4 million in the prior quarter.
- Across five years, Receivables - Other topped out at $56.6 million in Q2 2022 and bottomed at $300000.0 in Q1 2026.
- Historically, Receivables - Other has averaged $7.1 million across 5 years, with a median of $2.0 million in 2024.
- Annual changes were most pronounced in 2022 — Receivables - Other jumped 1910.15% — and 2023, when it sank 99.07%.
- Akebia Therapeutics' Receivables - Other stood at $781000.0 in 2022, then jumped by 326.76% to $3.3 million in 2023, then slumped by 39.69% to $2.0 million in 2024, then increased by 18.96% to $2.4 million in 2025, then slumped by 87.45% to $300000.0 in 2026.
- Business Quant data shows AKBA's Receivables - Other at $300000.0 in Q1 2026, $2.4 million in Q4 2025, and $500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 Mn |
| Jun 30, 2026 | 2.83 Mn |
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 2.39 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 2.69 Mn |
| Mar 31, 2024 | 2.69 Mn |